For instance, a Pin1 inhibitor all-trans retinoic acid has been used to treat acute promyelocytic leukemia in animal models and human patients [133], and all-trans retinoic acid reduced the growth of transplanted tamoxifen-resistant human breast cancer cells in mice [134]. The gene discussed is PIN1; the disease is acute promyelocytic leukemia.